Radaelli A, Mircoli L, Mori I, Mancia G, Ferrari A U
Centro di Fisiologia Clinica e Ipertensione, Cattedra di Cardioangiologia Medica, Università di Milano, Ospedale Maggiore, Milano, Italy.
Hypertension. 1998 Oct;32(4):735-9. doi: 10.1161/01.hyp.32.4.735.
Conflicting evidence exists on the possible impairment of tonic nitric oxide (NO) mediated vasodilation as a causative factor in the genesis of human as well as experimental hypertension. We evaluated the tonic NO-dependent vasodilation from the pressor response to NO synthesis inhibition by NG-monomethyl-L-arginine (L-NMMA) in 9 conscious, chronically instrumented spontaneously hypertensive rats (SHR) at 12 weeks of age, ie, during the early established hypertensive stage. Nine age-matched Wistar-Kyoto rats (WKY) were used as controls. The pressor responses to L-NMMA (100 mg . kg-1 IV bolus plus 1.5 mg . kg-1 . min-1 infusion for 60 minutes) as well as to non NO-dependent pressor stimuli, namely, vasopressin (2, 4, and 8 ng . kg-1) and phenylephrine (0.5, 1, and 2 microg . kg-1) given as IV boluses, were assessed both under control conditions and during suppression of autonomic reflexes by hexamethonium (30 mg . kg-1 IV bolus+1.5 mg . kg-1 . min-1 infusion). Rather than being reduced, the pressor responses to L-NMMA were 39% and 71% larger in the control and areflexic conditions, respectively, than those observed in WKY (both P<0.01). A similar pattern was observed for the pressor responses to vasopressin (+37% and +68% in the control and areflexic conditions, respectively; both P<0.01) and phenylephrine, (+20% and +52%; both P<0.05). Additional groups of 6-week-old prehypertensive SHR (n=11) and age-matched WKY (n=11) were subjected to an identical protocol: in these animals, the pressor responses to L-NMMA were similar in each strain, as were the pressor responses to vasopressin and phenylephrine in both control and areflexic conditions. In conclusion, our observations indicate that during the developmental phase of hypertension in the SHR model, namely, during the prehypertensive as well as the early established hypertensive stage, NO-dependent vasodilation is preserved (if not enhanced) so that a putative impairment of this function provides no significant pathogenic contribution to the onset of hypertension in this experimental model.
关于作为人类和实验性高血压发病原因之一的一氧化氮(NO)介导的张力性血管舒张功能可能受损,存在相互矛盾的证据。我们评估了12周龄、即处于早期高血压阶段的9只清醒、长期植入仪器的自发性高血压大鼠(SHR)中,从对NG-单甲基-L-精氨酸(L-NMMA)抑制NO合成的升压反应所反映出的NO依赖性张力性血管舒张功能。9只年龄匹配的Wistar-Kyoto大鼠(WKY)作为对照。分别在对照条件下以及六甲铵(30mg·kg-1静脉推注+1.5mg·kg-1·min-1输注)抑制自主反射期间,评估对L-NMMA(100mg·kg-1静脉推注加1.5mg·kg-1·min-1输注60分钟)以及对非NO依赖性升压刺激(即静脉推注血管加压素(2、4和8ng·kg-1)和去氧肾上腺素(0.5、1和2μg·kg-1))的升压反应。对L-NMMA的升压反应在对照和无反射条件下分别比在WKY中观察到的反应大39%和71%,而不是降低(均P<0.01)。对血管加压素(对照和无反射条件下分别为+37%和+68%;均P<0.01)和去氧肾上腺素(+20%和+52%;均P<0.05)的升压反应观察到类似模式。另外几组6周龄的高血压前期SHR(n = 11)和年龄匹配的WKY(n = 11)接受相同方案:在这些动物中,每个品系对L-NMMA的升压反应相似,在对照和无反射条件下对血管加压素和去氧肾上腺素的升压反应也相似。总之,我们的观察结果表明,在SHR模型高血压的发展阶段,即在高血压前期以及早期高血压阶段,NO依赖性血管舒张功能得以保留(如果不是增强的话),因此该功能的假定受损对该实验模型中高血压的发生没有显著的致病作用。